For some people with advanced stomach cancer, the drug nivolumab (Opdivo) plus chemotherapy may improve how long they live, results from a large clinical trial show. The trial also included patients with gastric cancers that involve the esophagus.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3dGrJBn
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3dGrJBn